Back to Journals » Therapeutics and Clinical Risk Management » Volume 9

Sampling times and genotyping concerns in bioequivalence evaluation of branded and generic formulations

Total article views   Abstract views HTML views PDF downloads Totals
7,575 Dovepress* 5,958 529+ 1,839 6,487
PubMed Central* 0 1,088 313 1,088
Totals 5,958 1,617 2,152 7,575
*Since 25 November 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 3 3

View citations on PubMed Central and Google Scholar